Anna Eshoo: “I come here today with a great sense of pride and I welcome the comments and the questions that members have asked.”

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

You did a great job, and I think that you answered--with your answers you were highly instructive to all of the members of the committee.

the words that we write walk into people's lives.

Simply put, we are not getting the best value for our healthcare dollar.